The stepped wedge trial design: a systematic review

Celia A Brown, Richard J Lilford, Celia A Brown, Richard J Lilford

Abstract

Background: Stepped wedge randomised trial designs involve sequential roll-out of an intervention to participants (individuals or clusters) over a number of time periods. By the end of the study, all participants will have received the intervention, although the order in which participants receive the intervention is determined at random. The design is particularly relevant where it is predicted that the intervention will do more good than harm (making a parallel design, in which certain participants do not receive the intervention unethical) and/or where, for logistical, practical or financial reasons, it is impossible to deliver the intervention simultaneously to all participants. Stepped wedge designs offer a number of opportunities for data analysis, particularly for modelling the effect of time on the effectiveness of an intervention. This paper presents a review of 12 studies (or protocols) that use (or plan to use) a stepped wedge design. One aim of the review is to highlight the potential for the stepped wedge design, given its infrequent use to date.

Methods: Comprehensive literature review of studies or protocols using a stepped wedge design. Data were extracted from the studies in three categories for subsequent consideration: study information (epidemiology, intervention, number of participants), reasons for using a stepped wedge design and methods of data analysis.

Results: The 12 studies included in this review describe evaluations of a wide range of interventions, across different diseases in different settings. However the stepped wedge design appears to have found a niche for evaluating interventions in developing countries, specifically those concerned with HIV. There were few consistent motivations for employing a stepped wedge design or methods of data analysis across studies. The methodological descriptions of stepped wedge studies, including methods of randomisation, sample size calculations and methods of analysis, are not always complete.

Conclusion: While the stepped wedge design offers a number of opportunities for use in future evaluations, a more consistent approach to reporting and data analysis is required.

Figures

Figure 1
Figure 1
Example of a stepped wedge study design.
Figure 2
Figure 2
Results of literature search.

References

    1. Soloman MJ, McLeod RS. Surgery and the randomised controlled trial: past, present and future. Medical Journal of Australia. 1998;169:380–383.
    1. Jadad A. Randomised Controlled Trials. London: BMJ Books; 1998.
    1. Cook TD, Campbell DT. Quasi-experimentation: Design and analysis issues for field settings. Boston, MA: Houghton Mifflin Company; 1979.
    1. Gambia Hepatitis Study Group The Gambia Hepatitis Intervention Study. Cancer Research. 1987;47:5782–5787.
    1. Smith PG, Morrow RH. Field Trials of Health Interventions in developing countries: A Toolbox. London: Macmillan Education Ltd; 1996.
    1. Lilford R. Formal measurement of clinical uncertainty: Prelude to a trial in perinatal medicine. British Medical Journal. 1994;308:111–112.
    1. Hutson AD, Reid ME. The utility of partial cross-over designs in early phase randomized prevention trials. Controlled Clinical Trials. 2004;25:493–501. doi: 10.1016/j.cct.2004.07.005.
    1. National evaluation of Surestart
    1. Belsky J, Melhuish E, Barnes J, Leyland AH, Romaniuk H, the National Evaluation of Sure Start Research Team Effects of Sure Start local programmes on children and families: early findings from a quasi-experimental, cross-sectional study. British Medical Journal, doi:101136/bmj388534517482F. published 16 June 2006.
    1. Surestart
    1. Barlow DH, Hersen M. Single case experimental designs: strategies for studying behaviour change. New York: Pergamon Press Inc; 1984.
    1. Hughes J, Goldenberg RL, Wilfert CM, Valentine M, Mwinga KS, Stringer JSA. Design of the HIV prevention trials network (HPTN) protocol 054: A cluster randomized crossover trial to evaluate combined access to Nevirapine in developing countries. UW Biostatistics Working Paper Series. 2003. p. 195.
    1. Chaisson RE, Durovni B, Cavalcante S, Golub JE, King B, Saraceni V, Efron A, Bishal D. The THRio Study. 2005. Further information about this study was obtained through contact with the authors.
    1. Somerville M, Basham M, Foy C, Ballinger G, Gay T, Shute P, Barton AG. From local concern to randomised trial: the Watcombe Housing Project. Health Expectations. 2002;5:127–135. doi: 10.1046/j.1369-6513.2002.00167.x.
    1. Fairley CK, Levy R, Rayner CR, Allardice K, Costello K, Thomas C, McArthur C, Kong D, Mijch A. Randomized trial of an adherence programme for clients with HIV. International Journal of STDs & AIDS. 2003;14:805–809. doi: 10.1258/095646203322556129.
    1. Levy RW, Rayner CR, Fairley CK, Kong DCM, Mijch A, Costello K, McArthur C. Multidisciplinary HIV adherence intervention: A randomized study. AIDS Patient Care and STDs. 2004;18:728–735. doi: 10.1089/apc.2004.18.728.
    1. Cook RF, Back A, Trudeau J. Substance abuse prevention in the workplace: Recent findings and an expanded conceptual model. Journal of Primary Prevention. 1996;16:319–339. doi: 10.1007/BF02407428.
    1. Bailey IW, Archer L. The impact of the introduction of treated water on aspects of community health in a rural community in Kwazulu-Natal, South Africa. Water Science and Technology. 2004;50:105–110.
    1. Wilmink TBM, Quick CRG, Hubbard CF, Day NE. The influence of screening on the incidence of ruptured abdominal aortic aneurysms. Journal of Vascular Surgery. 1999;30:203–208. doi: 10.1016/S0741-5214(99)70129-1.
    1. Grant AD, Charalambous S, Fielding KL, Day JH, Corbett EL, Chaisson RE, De Cock KM, Hayes RJ, Churchyard GJ. Effect of routine Isoniazid preventative therapy on Tuberculosis incidence among HIV-infected men in South Africa. Journal of the American Medical Association. 2005;22:2719–2725. doi: 10.1001/jama.293.22.2719.
    1. Ciliberto MA, Sandige H, Ndekha MJ, Ashorn P, Briend A, Ciliberto HM, Manary MJ. Comparison of home-based therapy with ready-to-use therapeutic food with standard therapy in the treatment of malnourished Malawian children: a controlled, clinical effectiveness trial. American Journal of Clinical Nutrition. 2005;81:864–870.
    1. Priestly G, Watson W, Rashidian A, Mozley C, Russell D, Wilson J, Cope J, Hart D, Kay D, Cowley K, Pateraki J. Introducing critical care outreach: A ward-randomised trial of phased introduction in a general hospital. Intensive Care Medicine. 2004;30:1398–1404.
    1. Moher D, Schultz KF, Altman DG, The CONSORT Group The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194. doi: 10.1016/S0140-6736(00)04337-3.
    1. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group CONSORT statement: Extension to cluster randomised trials. British Medical Journal. 2004;328:702–708. doi: 10.1136/bmj.328.7441.702.
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemparary Clinical Trials. 2006. doi: 10.1016/j.cct.2006.05.007.
    1. Askew I. Methodological issues in measuring the impact of interventions against female genital cutting. Culture, Health and Sexuality. 2005;7:463–477.
    1. Habicht JP, Victoria CG, Vaughan JP. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. International Journal of Epidemiology. 1999;28:10–18. doi: 10.1093/ije/28.1.10.
    1. NHS CRD: Commentary on. Oliver D, Hopper A, Seed P. Do hospital fall prevention programs work: A systematic review. Journal of the American Geriatrics Society. 2000;48:1679–1689.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel